Table 3-1.
Comparison of IL-6 and IL-10 concentrations, viral load, and neutralizing antibody titers between patients with fatal severe disease and patients with nonfatal severe disease.
| Patients | Age (years) /Sex | *Date | Severity | Outcome | IL-6 | IL-10 | Viral load (copies/mL) | FRNT50 titer (11) |
|---|---|---|---|---|---|---|---|---|
| P01-13 | 73/M | May-16-13 | Severe | Death | 2622.3 | 10.9 | 897.242.38 | 6.569 |
| P04-13 | 63/M | Jun-13-13 | Severe | Death | 117.2 | 8.2 | < 100 | 6.222 |
| P16-15 | 74/M | Jun-10-15 | Severe | Death | 61.4 | 45.6 | 15,527.11 | 0 |
| P49-18 | 81/F | Jun-12-18 | Severe | Recovered | 22.2 | 40.8 | 1,222,514.26 | 3.401 |
| P64-19 | 64/M | Aug-12-19 | Severe | Recovered | 5.6 | 5.6 | 48,766.65 | 0 |
| P66-19 | 60/F | Aug-28-19 | Severe | Recovered | 3.9 | 3.8 | 798.839.84 | 10.25 |
| P70-19 | 70/F | Oct-11-19 | Severe | Recovered | 7.1 | 7.1 | 101.288.97 | 13.53 |
Unit: pg/ml, *Date: The hospitalization and sampling date; P, positive; N, negative; FRNT50, 50% focus reduction neutralization test.